Compare EQT Corporation Common Stock (EQT) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EQT Corporation Common Stock vs Hinge Health Inc. Class A Common Stock — how do they compare? EQT Corporation Common Stock trades at $52.42 (market cap $34.05B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: EQT Corporation Common Stock is far larger — about 4× Hinge Health Inc. Class A Common Stock's market cap, and EQT Corporation Common Stock pays a 1.21% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold EQT Corporation Common Stock for 1 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| EQT | HNGE | |
|---|---|---|
Market Cap | $34.05B | $8.48B |
Volume | 4,662,584 | 879,799 |
Sector | Energy | Health |
52-Week High | $67.93 | $105.14 |
52-Week Low | $48.56 | $31.17 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $39.59B | $8.10B |
Dividend Yield | 1.21% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EQT trades at $54.43, up 2.27% today, with a bullish technical outlook and strong analyst consensus. The stock benefits from robust profitability, with a net income margin of 28.61% and a P/E ratio of 12.63. Recent news highlights a dividend increase and positive natural gas market tailwinds, while institutional buying activity supports sentiment. Earnings have mostly beaten expectations, with Q3 2026 results pending.
The outlook for EQT is positive, driven by operational efficiency, favorable natural gas demand, and a strong balance sheet. Risks include commodity price volatility and execution of growth plans. With a consensus price target of $70.33 implying significant upside, the stock presents a compelling opportunity for investors seeking exposure to the energy sector.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EQT Corporation Common Stock
EQT produces and transports natural gas, with production and midstream operations in the Appalachian Basin. Its operations are concentrated in Pennsylvania, West Virginia, and Ohio.
Read more on EQT →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
